# Individual Treatment of Ustekinumab in Perianal Fistulizing Crohn's Disease

> **NCT06739278** · — · NOT_YET_RECRUITING · sponsor: **Second Affiliated Hospital of Wenzhou Medical University** · enrollment: 119 (estimated)

## Conditions studied

- Crohn Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06739278
- **Lead sponsor:** Second Affiliated Hospital of Wenzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-20
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-01-31
- **Target enrollment:** 119 (ESTIMATED)
- **Last updated:** 2024-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06739278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06739278, "Individual Treatment of Ustekinumab in Perianal Fistulizing Crohn's Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06739278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*